1 ml of the suspension contains 40 mg micronised megestrol acetate (Megestroli acetas).
Excipient of known effect: sucrose
Megastril – medicinal product – is indicated in the treatment of anorexia or weight loss due to cancer or acquired immune deficiency syndrome (AIDS).
Hypersensitivity to the active substance or any of the excipients
Megastril is contraindicated in pregnancy and breast-feeding.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
1 ml of the suspension contains 40 mg micronised megestrol acetate (Megestroli acetas).
Excipient of known effect: sucrose
Megastril – medicinal product – is indicated in the treatment of anorexia or weight loss due to cancer or acquired immune deficiency syndrome (AIDS).
Hypersensitivity to the active substance or any of the excipients
Megastril is contraindicated in pregnancy and breast-feeding.
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
